Dr. Iacono

Aldo T. Iacono, M.D. Aldo T. Iacono, M.D.
Professor of Medicine
Medical Director, Lung Transplant Program

Department: Division
Medicine: Pulmonary and Critical Care Medicine

Special Interests: Aerosolized cyclosporine as anti-rejection medication; preventing complications of lung transplantation
Medical Degree: University of Bologna
Residency: Brooklyn Hospital; SUNY Downstate
Fellowship: SUNY Stony Brook
Certification: Internal Medicine; Pulmonary Diseases; Critical Care Medicine

Biography:

Dr. Iacono joined the University of Maryland faculty from University of Pittsburgh School of Medicine where he served as Medical Director of Lung Transplantation. Dr. Iacono has established a national reputation as an outstanding transplant pulmonologist and a translational investigator focusing on novel anti-rejection therapy. He has been a leader in developing aerosolized antirejection therapy to reduce the incidence of chronic lung transplant rejection and minimize systemic side effects of antirejection medications.

Current Research Interests:

  • Complications of lung transplantiation
  • Markers of lung transplant rejection
  • Novel anti-rejection therapies
  • Aerosolized anti-rejection therapy for lung transplant patients

Current Research Funding:

  • NIH R01 HL59490, “Aerosol Cyclosporine As Prevention of Allograft Rejection” (PI: Iacono) Years: 1997-2001. Direct cost: 1,706,795, Total Budget: 2,376,085
  • Chiron, “Commercialization of Aerosol Cyclosporine” (PI: Iacono); Years: 2004-present. Total Budget: $110,000

Education:

  • MD University of Bologna (1985)
  • House Staff Training; Brooklyn Hospital, SUNY Downstate (1989)
  • Fellowship training: SUNY Stony Brook (1992)

Contact Information:
1-800-373-4111 (physicians only)
1-800-492-5538 (patients only)
1-410-328-8919 (news media only)

This page was last updated: September 26, 2014

         
Average rating (6)